Household Identity in DTC Pharma: Uses, Limits, and Spillover
When household-level targeting fits DTC pharma, where it fails, and a risk matrix for intended and unintended exposure on shared devices.
The short answer
Much of DTC pharma media, especially connected TV, is delivered at the household level rather than to individuals. A household ID links devices that share an internet connection or address. This is useful for reach and frequency control. It also means the ad may be seen by people other than the intended viewer, which matters when the message concerns a health condition.
Where household identity works well
- Broad-reach video. CTV and streaming are household experiences. Household frequency caps prevent over-exposure.
- Conditions where the whole household is part of the audience. Family members often influence care decisions and may benefit from the information.
- Measurement at the household level. Some outcome studies measure exposure and outcomes by household, which can be appropriate when designed carefully.
Where it has limits
- Precision. Targeting a household because one member fits a segment means other members see the ad too. The effective on-target rate is lower than the segment accuracy suggests.
- Attribution. If a household is exposed and a prescription is filled, it may be for a different person than the one targeted.
- Sensitivity. An ad about a sensitive condition shown on a shared TV can reveal information to other household members.
The exposure risk matrix
| Low-sensitivity condition | High-sensitivity condition | |
|---|---|---|
| Broad contextual targeting | Low risk | Low to moderate risk |
| Household targeting from a health segment | Moderate risk | High risk; consider avoiding |
High-sensitivity conditions include those that carry stigma or that people commonly keep private. For these, contextual targeting or broad reach is often more appropriate than household targeting on health segments. The brand, privacy, and legal teams should agree on which conditions fall into which category.
Reduce spillover risk
- Use condition-neutral or disease-awareness creative in household channels where appropriate.
- Apply sensitive-context exclusions.
- Avoid building household audiences from the most sensitive data categories.
- Review whether the use passes the fitness-for-use gate.
Measurement implications
When measuring household-level campaigns, be clear about whether the outcome is measured for the targeted person or the household. Household-level outcomes can overstate effect if unrelated household members' prescriptions are counted. See deduplicated reach across CTV and online video and CTV frequency management.
Practical takeaway
Classify each DTC condition as low or high sensitivity with your privacy team. For high-sensitivity conditions, default to contextual and broad targeting in household channels, and require a documented exception to target households from health segments.
Sources
External guidance and platform documentation change. Links were current at publication; check them again before relying on them for a decision.
Editorial note. Analysis and frameworks are the author's own and do not represent Acxiom or any current or former employer, client, or named platform. Examples labeled hypothetical or illustrative are not results from real campaigns. Nothing here is legal, regulatory, or medical advice.
New pharma programmatic breakdowns, occasionally
One email when I publish something worth reading. Benchmarks, measurement teardowns, and case studies with the caveats attached. No cadence promises, no reselling your address.
Unsubscribe any time. See the privacy policy.
Working through this decision on a real plan?
I work on health and pharma data, identity, and activation, after five years running HCP and DTC programmatic agency-side. Happy to talk through how this applies to your situation.